GSC
IPSC icon

Ground Swell Capital’s Century Therapeutics IPSC Stock Holding History

Ground Swell Capital’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,176
Closed -$5.68K – 183
2025
Q2 		$5.68K Buy
+10,176
New +$5.46K 0.01% 135

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ground Swell Capital's IPSC Position: Q3 2025 in Review

Ground Swell Capital sold out of Century Therapeutics (IPSC) in Q3 2025, closing a stake of 10,176 shares — an estimated $5.68K sold.

Ground Swell Capital first reported a position in IPSC in Q2 2025 and held it in 1 quarter. The position peaked at $5.68K in Q2 2025. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • Ground Swell Capital reported no remaining Century Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Ground Swell Capital sold 10,176 Century Therapeutics shares in Q3 2025, an estimated $5.68K.
  • Ground Swell Capital first reported a position in Century Therapeutics in Q2 2025 and held it in 1 quarter.
  • Ground Swell Capital's Century Therapeutics position peaked at $5.68K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on Ground Swell Capital's 13F filing for Q3 2025, filed 6 Nov 2025.